Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 0.42%, near the low end of its 5-year range (0.00%–1.98%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
0.00%
DEBT TO ASSETS RATIO AVG 3Y
0.04%
DEBT TO ASSETS RATIO AVG 5Y
0.42%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 808 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Pasithea Therapeutics Corp.
Market Cap
$14.91M
Debt to Assets Ratio
0.00%
TTM Avg
0.00%
3Y Avg
0.04%
5Y Avg
0.42%
Market Cap
$15.25M
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.71M
Debt to Assets Ratio
0.69%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.98M
Debt to Assets Ratio
1.94%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.15M
Debt to Assets Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.86M
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.40M
Debt to Assets Ratio
0.77%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.72M
Debt to Assets Ratio
0.34%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pasithea Therapeutics Corp. (KTTA) | $14.91M | 0.00% | 0.00% | 0.04% | 0.42% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.25M | 0.29% | N/A | N/A | N/A |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.71M | 0.69% | N/A | N/A | N/A |
| BioCardia, Inc. (BCDA)vs › | $15.78M | 0.06% | N/A | N/A | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.98M | 1.94% | N/A | N/A | N/A |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.15M | N/A | N/A | N/A | N/A |
| Sintx Technologies, Inc. (SINT)vs › | $13.86M | 0.29% | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.40M | 0.77% | N/A | N/A | N/A |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $13.72M | 0.34% | N/A | N/A | N/A |
| Bionano Genomics, Inc. (BNGO)vs › | $16.52M | 0.14% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
26.25
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.15% |
| 2023-12-31 | 0.31% |
| 2023-09-30 | 1.26% |
| 2023-06-30 | 1.47% |
| 2023-03-31 | 1.74% |
| 2022-12-31 | 1.12% |
| 2022-09-30 | 1.98% |
| 2022-06-30 | 0.87% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
